Trial intelligence / Profile preview

Polyspectran drops vs glycerol ear drops for acute bacterial otitis externa

2005-001180-65Phase 3Completed

Sponsor
Alcon Inc.
Start
Sep 2005
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of neomycin sulfate + polymyxin B sulfate + gramicidin in external otitis (2 arms), sponsored by Alcon Inc. Primary endpoints: Efficacy outcome and Safety outcome. Started Sep 2005; status: completed.

02

Drugs

neomycin sulfate + polymyxin B sulfate + gramicidin
03

Conditions

external otitis

Beyond the preview

Go deeper on 2005-001180-65.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001180-65.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call